Oncology / Pharmacy Interface Expert Consultant

Request Expert / Similar Expert

Click “request expert” for a free initial screening call with this expert or a similar expert regarding your expert consulting needs

Summary

This Oncology/Pharmacy Interface Expert Consultant has completed his undergraduate and medical training at The University of Western Ontario, London, Canada. A medical oncologist, he has specialty board certifications from the Royal College of Physicians and Surgeons of Canada and the American Board of Internal Medicine. He also holds a Master of Science in business administration from Madonna University, Livonia, Michigan. His previous positions include director of Biometry and Outcome Measurement, London Regional Cancer Center, and director of quality assurance and associate professor of medicine at the Barbara Ann Karmanos Cancer Institute at Wayne State University, Detroit; most recently he was vice president and medical director of cancer services for Baystate Health and professor of medicine at University of Massachusetts Medical School–Baystate.

This Expert Consultant has a robust experience in cancer program design, strategy and operations, with expertise in the oncology/pharmacy interface, as well as high-value cancer care delivery, particularly involving antineoplastic drug management and implementation of value-based practice in radiation oncology. He has led several cancer facility design initiatives, most prominently the design, construction and operation of Baystate Health’s D’Amour Center for Cancer Care, which opened in 2004.

An accomplished medical oncologist and physician executive, this Consultants research interests include medical management topics, cancer patient supportive care, and informatics in cancer management. His clinical practice has focused on head and neck, thoracic oncology, and unusual tumors.

Highlights

• 30+ years in medical oncology practice
• 25 years of cancer program physician executive experience, both strategy and operations
• Widely published in oncology clinical trials, supportive care topics, and oncology informatics
• Considerable expertise in DSP/340B pharmacy issues
• Experience in leading, and participating, in facility development/design/rollout and operations teams
• Experienced in cancer clinical trial authoring and management
• Experienced in hospital-based cancer programs, including management of satellite facilities
• Experience in management of integrated comprehensive breast programs
• Experienced in implementing supportive care management in cancer across multiple hospitals
• Certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Internal Medicine in internal medicine and medical oncology

Relevant Accomplishments

• Served as clinical leader of cancer services for Baystate Health; implemented a relevant strategy that increased market share from 15% of hematology-oncology in western Massachusetts to almost 70%, and led radiation oncology to be the dominant program in the region, and the only one providing stereotactic body radiotherapy as well as high dose-rate and surface brachytherapy
• Led the design/construction/operations team for the development and implementation of the D’Amour Center for Cancer Care, a 65,000 sq ft facility costing $38M with unique clinical integration, opened on time and on budget 2004
• Let the design and operations team for the redevelopment of the oncology unit at Baystate Mary Lane Hospital (2018), Baystate Wing Hospital (2020), and the creation of the D’Amour Center Annex (2022), to account for growing volumes
• Has led teams in the replacement of linear accelerators three times.
• Developed an interdisciplinary supportive care clinic for patients receiving concurrent chemoradiation for head and neck malignancies, as well as anorectal cancers, significantly reducing hospitalizations while achieving almost universal on-time radiation completion rates. Expanded services to patients with complex end-of-life issues in partnership with Baystate Hospice and Home Care.
• Developed quality assessment programs to ensure compliance with key process and outcome metrics; participated in ASCO’s QOPI program, with the cancer program becoming the first certified by QOPI in Massachusetts, with high certification scores
• Participates with BayCare, Inc., Baystate’s physician/hospital organization focused on managing cancer cost and quality for their Medicaid and NextGen Medicare ACO’s. Cost of Part B drugs per member per month for BayCare’s NextGen ACO is the second lowest for all NextGen ACO’s, largely driven by oncology-based agents. Data from Sg2 suggests that Baystate’s cancer program is responsible for approximately 28% of oncology drug costs for western Massachusetts, despite Baystate’s almost 70% market share
• Development of an oncology- and infusion-specific pharmacy and therapeutics subcommittee for Baystate Health and Harper Hospital
• Developed a sickle cell day hospital program that reduced red cell disorder DGR days/year at North Oakland Medical Centers, Pontiac MI, from 2350 days (1997) to 277 (1999)
• Reduced inpatient oncology volume at Harper Hospital by 65% through expansion of outpatient chemotherapy services
• Standardized antiemetic management at Harper Hospital (1996) and subsequently the rest of Detroit Medical Center (1997), reducing costs and increasing compliance with international guidelines.

Roles

• Vice President and Medical Director, Cancer Services, Baystate Health, 2013-2022
  • Chief, Division of Hematology Oncology, Baystate Medical Center, 2018-2022
  • Medical Director, Cancer Services, Baystate Health, 2000-2013
• University of Massachusetts Chan Medcal School—Baystate
  • Professor 2019-
• Tufts University School of Medicine
  • Professor 2012-2019
  • Associate Professor 2003-2012
• Medical Director, Cancer Services, North Oakland Medical Center, 1997-2000
• Associate Professor of Medicine, Hematology Oncology, Wayne Statre University 1995-1997
  • Director, Quality Assurance, Karmanos Cancer Institute, 1995-1997
• Medical Coordinator, Clinical Research Programme, Department of Biometry and Outcome Measurement, London Regional Cancer Centre, London, Ontario
• University of Western Ontario
  • Associate Professor 1994-1995
  • Assistant Professor 1989-1994

Request Expert / Similar Expert

Click “request expert” for a free initial screening call with this expert or a similar expert regarding your expert consulting needs